Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
01/2011
01/20/2011US20110015176 Substituted heteroarylamide oxazepinopyrimidone derivatives
01/20/2011US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses
01/20/2011CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
01/20/2011CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
01/20/2011CA2768210A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
01/20/2011CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases
01/19/2011EP2274983A1 Harmful arthropod control composition, and fused heterocyclic compound
01/19/2011EP2274286A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof
01/19/2011CN101948475A Isoflavone derivate-chromene (chroman) oxazines compound, preparation method and application thereof
01/19/2011CN101948444A synthesized small molecular compound capable for transferring bioactive substances and applications thereof
01/19/2011CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same
01/19/2011CN101153043B Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
01/18/2011US7872128 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases
01/18/2011US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates
01/18/2011US7872122 reacting sirolimus with 2-ethoxyethyl pentafluorobenzene sulfonate under catalyzing condition using ethyl diiospropylamine or 2, 6-dimethyl pyridine as basic catalyst in the presence of an organic solvent (dichloromethane) to undergo a nucleophilic substitution reaction to obtain Biolimus A9
01/18/2011CA2477769C Ophthalmic composition comprising ascomycin
01/13/2011WO2011005738A1 Bace inhibitors
01/13/2011WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
01/13/2011WO2011003604A1 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
01/13/2011WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
01/13/2011US20110009639 Synthesis of enone intermediate
01/13/2011US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
01/13/2011US20110009619 Polycyclic compound
01/13/2011US20110009618 Methods of manufacturing crystalling forms of rapamycin analogs
01/13/2011US20110009617 Ruthenium Catalysts and Uses Thereof
01/13/2011US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
01/13/2011US20110009392 Gamma secretase modulators
01/13/2011US20110009389 Imidazole derivative, their production and use
01/13/2011US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles
01/13/2011US20110008288 Hepatitis c virus inhibitors
01/13/2011CA2767476A1 Indazolyl-substituted dihydroisoxazolopyridines and methods of use thereof
01/13/2011CA2764429A1 Condensed aminodihydrothiazine derivatives as bace inhibitors
01/12/2011EP2272935A1 Ultraviolet absorbent compositions
01/12/2011EP2272850A2 Process for purifying staurosporine
01/12/2011EP2271650A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
01/12/2011EP2271625A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/12/2011EP2271345A1 Hcv ns3 protease inhibitors
01/12/2011EP1682138B1 Heterocyclic inhibitors of mek
01/12/2011CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
01/12/2011CN101945853A Selective androgen receptor modulators (sarms) and uses thereof
01/12/2011CN101944571A Single-layer organic el device
01/12/2011CN101941979A New production process of rifamycin sodium
01/12/2011CN101445510B Pyridine macrocyclic crown ether-based stilbene compound
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
01/11/2011CA2430124C Lactam compounds and pharmaceutical use thereof
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/06/2011WO2011000481A1 Synthesis of pyrazine derivates
01/06/2011US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
01/06/2011US20110003986 Synthesis of 2,4-Pyrimidinediamines
01/06/2011US20110003969 Conjugation methods
01/06/2011US20110003840 Pyridoindolobenzox-and thiazepine derivatives and uses thereof
01/06/2011US20110003806 Heteroaryls and uses thereof
01/06/2011US20110003803 Compositions and methods for treating ophthalmic, otic, or nasal infections
01/06/2011US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
01/06/2011US20110003801 Benzimidazole derivatives useful as trpm8 channel modulators
01/06/2011US20110003800 Benzimidazole derivatives useful as trpm8 channel modulators
01/06/2011US20110003798 Compounds and compositions as kinase inhibitors
01/06/2011US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors
01/06/2011US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives
01/06/2011US20110003385 Regulated transcription of targeted genes and other biological events
01/06/2011US20110002884 Therapeutic compounds
01/05/2011EP2270113A1 Ultraviolet absorbent compositions
01/05/2011EP2269651A2 Stabilisation of macrolides
01/05/2011EP2269604A1 Treatment of solid tumours with rapamycin derivatives
01/05/2011EP2269603A1 Treatment of solid tumours with rapamycin derivatives
01/05/2011EP2268646A2 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
01/05/2011EP2268645A1 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur
01/05/2011EP2268636A1 Gamma secretase modulators
01/05/2011EP2268146A1 Indoline anti-cancer agents
01/05/2011EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same
01/05/2011CN101939315A Gamma secretase modulators
01/05/2011CN101939312A Gamma secretase modulators
01/05/2011CN101939302A Mesoionic pesticides
01/05/2011CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application
01/04/2011US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
01/04/2011US7863288 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents
01/04/2011US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct
01/04/2011CA2454703C Novel thiophene carboxamide derivatives
12/2010
12/30/2010US20100331348 Tropane derivatives useful as pesticides
12/30/2010US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/30/2010US20100331310 Bicycloamine derivatives
12/30/2010US20100331305 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
12/30/2010US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010EP2266989A2 Heterocyclic derivatives
12/29/2010EP2266968A2 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
12/29/2010EP2265620A1 Spiro derivatives of parthenin as novel anticancer agents
12/29/2010EP2265601A1 Pyridazine derivatives as factor xia inhibitors
12/29/2010EP2265275A2 Antiviral therapeutic agents
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN101932578A Gamma secretase modulators
12/29/2010CN101928291A Method for separating and purifying ansamitocin from precious orange synnema actinomycetes fermentation liquor
12/29/2010CN101928290A Method for purifying pazufloxacin mesylate
12/29/2010CN101103029B 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 220